MENU
+Compare
ARAY
Stock ticker: NASDAQ
AS OF
Jul 16, 11:25 AM (EDT)
Price
$1.34
Change
+$0.01 (+0.75%)
Capitalization
244.95M

ARAY Accuray Forecast, Technical & Fundamental Analysis

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives... Show more

ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ARAY with price predictions
Jul 15, 2025

ARAY in downward trend: price expected to drop as it breaks its higher Bollinger Band on June 27, 2025

ARAY broke above its upper Bollinger Band on June 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 39 similar instances where the stock broke above the upper band. In of the 39 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 14, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ARAY as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARAY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ARAY's RSI Indicator exited the oversold zone, of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for ARAY just turned positive on June 25, 2025. Looking at past instances where ARAY's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ARAY advanced for three days, in of 248 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.015) is normal, around the industry mean (24.469). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.519) is also within normal values, averaging (42.883).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ARAY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARAY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ARAY is expected to report earnings to fall 700.00% to 5 cents per share on August 14

Accuray ARAY Stock Earnings Reports
Q2'25
Est.
$0.06
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.01
Q2'24
Est.
$0.03
The last earnings report on April 30 showed earnings per share of 0 cents, beating the estimate of -3 cents. With 143.24K shares outstanding, the current market capitalization sits at 244.95M.
A.I. Advisor
published General Information

General Information

a manufacturer of medical equipment

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1240 Deming Way
Phone
+1 608 824-2800
Employees
1024
Web
https://www.accuray.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KLBAY7.140.26
+3.71%
Klabin S.A.
HENKY18.220.05
+0.27%
Henkel AG & Co. KGAA
JVTSF3.60N/A
N/A
JUVENTUS FOOTBALL CLUB SPA, TORINO
LOVFF1.26-0.08
-5.83%
Cannara Biotech Inc.
EWPMF0.03-0.01
-17.91%
East West Petroleum Corp.

ARAY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ARAY has been loosely correlated with ALGN. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ARAY jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARAY
1D Price
Change %
ARAY100%
-2.21%
ALGN - ARAY
46%
Loosely correlated
-3.26%
ILMN - ARAY
44%
Loosely correlated
-1.40%
KIDS - ARAY
44%
Loosely correlated
-0.63%
A - ARAY
42%
Loosely correlated
-5.95%
NVST - ARAY
41%
Loosely correlated
-1.10%
More